Publication | Open Access

The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia

Cannabis UseMedicineLevodopa-induced DyskinesiaPharmacologyNeuropharmacologyCannabinoid Type 1NeurologyNeuroscienceDopamineNeuropathologyBasal GangliaNeurochemistryCannabinoidsSocial SciencesNeuropeptides